Cargando…

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma

Ferroptosis is an iron-dependent cell death process that plays important regulatory roles in the occurrence and development of cancers, including hepatocellular carcinoma (HCC). Moreover, the molecular events surrounding aberrantly expressed long non-coding RNAs (lncRNAs) that drive HCC initiation a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhijie, Peng, Bi, Liang, Qiuju, Chen, Xi, Cai, Yuan, Zeng, Shuangshuang, Gao, Kewa, Wang, Xiang, Yi, Qiaoli, Gong, Zhicheng, Yan, Yuanliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484522/
https://www.ncbi.nlm.nih.gov/pubmed/34603293
http://dx.doi.org/10.3389/fimmu.2021.719175
_version_ 1784577335066886144
author Xu, Zhijie
Peng, Bi
Liang, Qiuju
Chen, Xi
Cai, Yuan
Zeng, Shuangshuang
Gao, Kewa
Wang, Xiang
Yi, Qiaoli
Gong, Zhicheng
Yan, Yuanliang
author_facet Xu, Zhijie
Peng, Bi
Liang, Qiuju
Chen, Xi
Cai, Yuan
Zeng, Shuangshuang
Gao, Kewa
Wang, Xiang
Yi, Qiaoli
Gong, Zhicheng
Yan, Yuanliang
author_sort Xu, Zhijie
collection PubMed
description Ferroptosis is an iron-dependent cell death process that plays important regulatory roles in the occurrence and development of cancers, including hepatocellular carcinoma (HCC). Moreover, the molecular events surrounding aberrantly expressed long non-coding RNAs (lncRNAs) that drive HCC initiation and progression have attracted increasing attention. However, research on ferroptosis-related lncRNA prognostic signature in patients with HCC is still lacking. In this study, the association between differentially expressed lncRNAs and ferroptosis-related genes, in 374 HCC and 50 normal hepatic samples obtained from The Cancer Genome Atlas (TCGA), was evaluated using Pearson’s test, thereby identifying 24 ferroptosis-related differentially expressed lncRNAs. The least absolute shrinkage and selection operator (LASSO) algorithm and Cox regression model were used to construct and validate a prognostic risk score model from both TCGA training dataset and GEO testing dataset (GSE40144). A nine-lncRNA-based signature (CTD-2033A16.3, CTD-2116N20.1, CTD-2510F5.4, DDX11-AS1, LINC00942, LINC01224, LINC01231, LINC01508, and ZFPM2-AS1) was identified as the ferroptosis-related prognostic model for HCC, independent of multiple clinicopathological parameters. In addition, the HCC patients were divided into high-risk and low-risk groups according to the nine-lncRNA prognostic signature. The gene set enrichment analysis enrichment analysis revealed that the lncRNA-based signature might regulate the HCC immune microenvironment by interfering with tumor necrosis factor α/nuclear factor kappa-B, interleukin 2/signal transducers and activators of transcription 5, and cytokine/cytokine receptor signaling pathways. The infiltrating immune cell subtypes, such as resting memory CD4(+) T cells, follicular helper T cells, regulatory T cells, and M0 macrophages, were all significantly different between the high-risk group and the low-risk group as indicated in Spearman’s correlation analysis. Moreover, a substantial increase in the expression of B7H3 immune checkpoint molecule was found in the high-risk group. Our findings provided a promising insight into ferroptosis-related lncRNAs in HCC and a personalized prediction tool for prognosis and immune responses in patients.
format Online
Article
Text
id pubmed-8484522
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84845222021-10-02 Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma Xu, Zhijie Peng, Bi Liang, Qiuju Chen, Xi Cai, Yuan Zeng, Shuangshuang Gao, Kewa Wang, Xiang Yi, Qiaoli Gong, Zhicheng Yan, Yuanliang Front Immunol Immunology Ferroptosis is an iron-dependent cell death process that plays important regulatory roles in the occurrence and development of cancers, including hepatocellular carcinoma (HCC). Moreover, the molecular events surrounding aberrantly expressed long non-coding RNAs (lncRNAs) that drive HCC initiation and progression have attracted increasing attention. However, research on ferroptosis-related lncRNA prognostic signature in patients with HCC is still lacking. In this study, the association between differentially expressed lncRNAs and ferroptosis-related genes, in 374 HCC and 50 normal hepatic samples obtained from The Cancer Genome Atlas (TCGA), was evaluated using Pearson’s test, thereby identifying 24 ferroptosis-related differentially expressed lncRNAs. The least absolute shrinkage and selection operator (LASSO) algorithm and Cox regression model were used to construct and validate a prognostic risk score model from both TCGA training dataset and GEO testing dataset (GSE40144). A nine-lncRNA-based signature (CTD-2033A16.3, CTD-2116N20.1, CTD-2510F5.4, DDX11-AS1, LINC00942, LINC01224, LINC01231, LINC01508, and ZFPM2-AS1) was identified as the ferroptosis-related prognostic model for HCC, independent of multiple clinicopathological parameters. In addition, the HCC patients were divided into high-risk and low-risk groups according to the nine-lncRNA prognostic signature. The gene set enrichment analysis enrichment analysis revealed that the lncRNA-based signature might regulate the HCC immune microenvironment by interfering with tumor necrosis factor α/nuclear factor kappa-B, interleukin 2/signal transducers and activators of transcription 5, and cytokine/cytokine receptor signaling pathways. The infiltrating immune cell subtypes, such as resting memory CD4(+) T cells, follicular helper T cells, regulatory T cells, and M0 macrophages, were all significantly different between the high-risk group and the low-risk group as indicated in Spearman’s correlation analysis. Moreover, a substantial increase in the expression of B7H3 immune checkpoint molecule was found in the high-risk group. Our findings provided a promising insight into ferroptosis-related lncRNAs in HCC and a personalized prediction tool for prognosis and immune responses in patients. Frontiers Media S.A. 2021-09-17 /pmc/articles/PMC8484522/ /pubmed/34603293 http://dx.doi.org/10.3389/fimmu.2021.719175 Text en Copyright © 2021 Xu, Peng, Liang, Chen, Cai, Zeng, Gao, Wang, Yi, Gong and Yan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Xu, Zhijie
Peng, Bi
Liang, Qiuju
Chen, Xi
Cai, Yuan
Zeng, Shuangshuang
Gao, Kewa
Wang, Xiang
Yi, Qiaoli
Gong, Zhicheng
Yan, Yuanliang
Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
title Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
title_full Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
title_fullStr Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
title_full_unstemmed Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
title_short Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
title_sort construction of a ferroptosis-related nine-lncrna signature for predicting prognosis and immune response in hepatocellular carcinoma
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484522/
https://www.ncbi.nlm.nih.gov/pubmed/34603293
http://dx.doi.org/10.3389/fimmu.2021.719175
work_keys_str_mv AT xuzhijie constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT pengbi constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT liangqiuju constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT chenxi constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT caiyuan constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT zengshuangshuang constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT gaokewa constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT wangxiang constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT yiqiaoli constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT gongzhicheng constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma
AT yanyuanliang constructionofaferroptosisrelatedninelncrnasignatureforpredictingprognosisandimmuneresponseinhepatocellularcarcinoma